Calcitonin gene‐related peptide ( CGRP ) in epilepsy: Mechanistic insights from preclinical models
Epilepsia Open · 13.11.2026
DOI: 10.1002/epi4.70363 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Epilepsia Open, online erschienen am 13.11.2026. Verfasst von Marina Romozzi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento Universitario di Neuroscienze, Università Cattolica del Sacro Cuore, Rome, Italy. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Calcitonin gene‐related peptide (CGRP) is a pleiotropic neuropeptide widely expressed in the central and peripheral nervous systems, with established roles in neurovascular regulation, synaptic transmission, and neuroinflammation. While CGRP has been extensively characterized in migraine pathophysiology, its role in epilepsy remains incompletely defined and is primarily supported by experimental evidence. Preclinical studies consistently demonstrate CGRP upregulation following prolonged seizures, particularly in models of status epilepticus, and suggest that CGRP signaling may contribute to key processes implicated in epileptogenesis. These include modulation of neuronal excitability, blood–brain barrier permeability, and neuroimmune responses, such as microglial activation. At the same time, CGRP has been shown to engage neuroprotective pathways, including anti‐apoptotic and anti‐oxidative mechanisms, as well as barrier‐stabilizing effects, supporting a complex and context‐dependent role. Shared pathophysiological features between migraine and epilepsy, such as cortical hyperexcitability, neuroinflammation, and cortical spreading depolarization, provide a conceptual framework in which CGRP may act as a convergent mechanistic mediator. However, direct evidence in human epilepsy remains limited, and the translational relevance of these findings requires careful interpretation. This review provides a focused synthesis of mechanistic insights from experimental models, highlighting the dual role of CGRP in seizure‐related processes and delineating current gaps in knowledge. Potential clinical implications, including the effects of CGRP‐targeting therapies, are discussed in a hypothesis‐generating context, with emphasis on the need for rigorous studies to clarify their relevance in epilepsy. Plain Language Summary Migraine and epilepsy sometimes occur together and share changes in brain activity. This review examines CGRP, a signaling molecule involved in migraine, and its possible role in seizures. Animal studies suggest that CGRP can either increase abnormal brain activity and inflammation or protect nerve cells, depending on the conditions. Early observations in people raise the possibility that migraine medicines blocking CGRP could also affect seizures, but they do not prove a benefit. Further research is needed to determine whether these medicines can safely reduce seizures or prevent epilepsy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dipartimento Universitario di Neuroscienze, Università Cattolica del Sacro Cuore, Rome, Italy.
- Dipartimento di Neuroscienze, Organi di Senso e Torace, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
- Department of Biomedical, Metabolic, and Neural Science, University of Modena and Reggio Emilia, Modena, Italy.
- Department of Psychiatry and Behavioral Sciences, University of Miami, Miami, Florida, USA.
- Università Telematica San Raffaele di Roma, Rome, Italy.
- San Raffaele Sulmona, Sulmona, L'Aquila, Italy.
ORCID-Profile: Marina Romozzi
Zitieren
APA
Romozzi, M., Pani, L., Benatti, C., Vollono, C., Canonichesi, J., Servidei, S., Calabresi, P., Tascedda, F., & Iannone, L. F. (2026). Calcitonin gene‐related peptide ( CGRP ) in epilepsy: Mechanistic insights from preclinical models. Epilepsia Open. https://doi.org/10.1002/epi4.70363
Vancouver
Romozzi M, Pani L, Benatti C, Vollono C, Canonichesi J, Servidei S, et al. Calcitonin gene‐related peptide ( CGRP ) in epilepsy: Mechanistic insights from preclinical models. Epilepsia Open. 2026. doi:10.1002/epi4.70363
BibTeX
@article{Romozzi2026,
author = {Romozzi, Marina and Pani, Luca and Benatti, Cristina and Vollono, Catello and Canonichesi, Jacopo and Servidei, Serenella and Calabresi, Paolo and Tascedda, Fabio and Iannone, Luigi Francesco},
title = {Calcitonin gene‐related peptide ( CGRP ) in epilepsy: Mechanistic insights from preclinical models},
journal = {Epilepsia Open},
year = {2026},
doi = {10.1002/epi4.70363}
}
EUVIMED